感染性肾下腹主动脉瘤不同管理方式的结局
该回顾性队列研究分析了2016年7月至2022年10月单中心23例感染性肾下腹主动脉瘤患者,比较开放手术、EVAR及保守治疗的结果。初始开放手术7例全部存活,初始EVAR14例感染均恶化,总体死亡率39.1%。作者认为开放手术仍是血流动力学稳定低危患者的首选,单纯EVAR应作为临时替代并适时二次开放手术。
要点
- 初始开放手术7例随访期间全部存活,初始EVAR14例感染全部恶化。
- 总体死亡率39.1%(9/23),保守治疗2例30天内死亡。
- 初始EVAR未二次手术者死亡率100%,二次手术者死亡率36.4%。
核心结论
- 作者认为开放手术修复仍是血流动力学稳定且低危患者的首选。
- 作者认为单纯EVAR与灾难性结果相关,应保留为破裂动脉瘤、血流动力学不稳定或手术高风险患者的临时替代方案,并随后及时行二次开放手术修复。
研究设计与样本
- 回顾性队列研究,分析本中心2016年7月至2022年10月管理的感染性肾下腹主动脉瘤患者数据。
- 共纳入23例患者(21例男性;平均66.3岁,范围49-79岁),平均随访19.9个月(范围1-75个月)。
- 诊断依据包括术前感染临床征象、血清学感染指标升高、增强CT示动脉瘤旁感染特征、血或组织培养阳性。
- 所有患者接受标准抗生素治疗;根据疾病严重程度、身体状况和患者意愿选择EVAR、初始EVAR后开放再手术或初始开放手术修复。
主要发现
- 血或组织标本培养阳性15例:沙门菌8例,大肠埃希菌3例,甲氧西林敏感金黄色葡萄球菌(MSSA)1例,肺炎克雷伯菌1例,表皮葡萄球菌1例,结核分枝杆菌1例。
- 7例以开放手术作为初始干预,随访至今均存活;14例初始选择EVAR。
- 2例保守治疗(拒绝手术)患者在30天内死亡。
- 初始EVAR的14例患者感染无一例外均恶化(14/14,100%);其中3例拒绝再手术并在6个月内死亡。
- 11例接受二次外科干预(10例行动脉瘤及内移植物切除、彻底清创、锁骨下动脉至双股动脉旁路或原位主动脉重建;1例腹腔镜清创),其中7例随访期间存活;总体死亡率为39.1%(9/23)。
关键数值与推荐
- 不同干预方式的死亡率差异很大:仅抗生素管理100%;初始开放手术0%;初始EVAR未二次手术100%;初始EVAR加二次手术36.4%。
临床怎么用
- 作者认为开放手术修复仍是血流动力学稳定且低危患者的首选。
- 作者认为单纯EVAR与灾难性结果相关,应保留为破裂动脉瘤、血流动力学不稳定或手术高风险患者的临时替代方案,并随后及时行二次开放手术修复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective was to present our experience on managing mycotic infrarenal abdominal aortic aneurysm (MIAAA) through a retrospective cohort study. METHODS: Data of patients with MIAAA managed in our center from July 2016 to October 2022 were retrospectively analyzed. The diagnosis of MIAAA was made based on: (1) preoperative clinical signs of infection; (2) elevated serologic infection parameters; (3) para-aneurysmal infection features on enhanced computed tomography; and (4) positive blood or tissue cultures. All the patients received standard antibiotic therapy. Surgical management including endovascular aneurysm repair (EVAR), initial EVAR followed by open re-operation, and initial open surgical repair (OSR) were conducted according to disease seriosity, physical condition, and patient's will. Infection index and clinical outcome were evaluated during the follow-up time. RESULTS: A total of 23 patients (21 men; averaged=66.3 years, range=49-79 years) were included, with a mean follow-up time of 19.9 months (range=1-75 months). Bacteria culture from blood or tissue specimen was positive in 15 patients (Salmonella, n=8; Escherichia coli, n=3; methicillin-sensitive Staphylococcus aureus [MSSA], n=1; Klebsiella pneumoniae, n=1; Staphylococcus epidermidis, n=1; Mycobacterium tuberculosis, n=1). Seven patients received OSR as the initial surgical intervention, whereas 14 patients chose EVAR instead. The 2 conservatively managed patients (refused surgery) died within 30 days. The 7 patients who received initial OSR survived till now. Among the 14 patients who underwent initial EVAR, infection deteriorated without exception (14/14, 100%). Three of these patients refused re-operation and died within 6 months. Eleven patients received secondary surgical intervention (10 cases of aneurysm and endograft resection, thorough debridement, subclavian to bi-femoral artery bypass, or in situ aorta reconstruction; 1 case of laparoscopic debridement) and 7 survived the follow-up time. The overall mortality rate was 39.1% (9/23). The mortality rates differed greatly following different intervention methods (merely antibiotic management, 100%; initial open operation, 0%; initial EVAR without secondary operation, 100%; initial EVAR plus secondary operation, 36.4%). CONCLUSIONS: Open surgical repair is still the first choice for hemodynamically stable and low-risk patients. Merely EVAR is related with disastrous results, which should be reserved as a temporary alternative for patients with ruptured aneurysms, hemodynamic instability or high surgical risk, and followed by timely secondary OSR.Clinical ImpactThe management of mycotic or primary-infected aortic aneurysm is challenging; treatment remains controversial. Our center has reviewed our experience over the past 6 years and found that open surgical repair is still the first choice for hemodynamically stable and low-risk patients. Merely endovascular aneurysm repair (EVAR) is related with disastrous results, which should be reserved as a temporary alternative for patients with ruptured aneurysms, hemodynamic instability or high surgical risk, and followed by timely secondary open surgical repair.
引用
- Lin R, He HP, Zhao Y, et al. Outcomes Following Different Management of Mycotic Infrarenal Abdominal Aortic Aneurysms. J Endovasc Ther. 2024. PMID: 38733303. doi:10.1177/15266028241253128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。